The directors of Asarina Pharma have abandoned a search for a partner for Tourette's syndrome treatment sepranolone, saying they have no choice but to liquidate the company. Just over a year ago ...

In the Phase III trial, 41.9% of pediatric Tourette syndrome patients relapsed after ecopipam treatment, as compared with ...

from Asarina Pharma AB. The compound is being developed as a potential first-line treatment for Tourette syndrome (TS) and other compulsive disorders. According to InvestingPro data, the company ...

The clinical-stage biotechnology firm acquired Sepranolone, a potential first-line treatment for Tourette syndrome from Asarina Pharma AB, for EUR 3 million. The compound has shown promising ...

Algernon Pharmaceuticals (AGNPF) announced that its wholly owned subsidiary Algernon NeuroScience, has appointed Netcapital Securities for its ...

Clearmind Medicine (CMND) announced the publication of a patent by the Korean Intellectual Property Office, South Korea’s official patent and ...

GH Research Plc operates as a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients of psychiatric and ...

After hours: March 10 at 7:37:16 PM EDT Loading Chart for RLMD ...